<DOC>
	<DOCNO>NCT00917826</DOCNO>
	<brief_summary>The purpose study ass whether administration Arginine Butyrate + ganciclovir/valganciclovir three 21-day cycle tolerable , result partial complete response patient EBV ( + ) lymphoid malignancy .</brief_summary>
	<brief_title>Study Arginine Butyrate Ganciclovir/Valganciclovir EBV ( + ) Lymphoid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Lymphoproliferative Disorders</mesh_term>
	<mesh_term>Ganciclovir</mesh_term>
	<mesh_term>Valganciclovir</mesh_term>
	<mesh_term>Ganciclovir triphosphate</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<mesh_term>Arginine butyrate</mesh_term>
	<criteria>Age ≥ 3 year . ( No dose adverse event data currently available use valganciclovir patient &lt; 16 year age . ) Life expectancy &gt; 3 month . ECOG Performance Status 02 Karnofsky Performance Scale ≥ 60 % . Baseline ( untransfused ) HbF level &gt; 2 % Normal organ marrow function define : ( ) absolute neutrophil count ≥ 1,000/µL . ( ii ) platelets ≥ 50,000/ µL . ( iii ) total bilirubin ≤ 2.0 x upper limit normal . ( iv ) AST ( SGOT ) /ALT ( SGPT ) ≤ 2.0 x institutional upper limit normal . ( v ) creatinine within normal range institution . Women childbearing potential men must agree use adequate contraception prior study entry duration study participation . Able willing give inform consent . Patients receive chemotherapy radiotherapy within 4 week ( 6 week nitrosoureas mitomycin C ) prior entry , recover form adverse event due agent administer 4 week earlier . Patients may receive investigational agent . History allergic reaction attribute compound similar chemical biologic composition Arginine Butyrate , ganciclovir valganciclovir . Patients acute myocardial infarction onset atrial fibrillation within past 6 month . Uncontrolled intercurrent illness include , limited , ongoing active infection , symptomatic congestive heart failure , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Tumor impinge organ anatomical structure deem critical investigator . Pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>